Advanced alcoholic liver disease driven by a proferroptotic diet

Area of Science:

• Hepatology
• Nutritional Science
• Toxicology

Background:

• Alcoholic liver disease (ALD) presents a spectrum of conditions, with advanced stages marked by liver fibrosis and high mortality.
• The standard Lieber-DeCarli (LD) mouse model for ALD often fails to progress to advanced stages.
• Previous research identified ferroptosis as a key mechanism of liver injury in this model.

Purpose of the Study:

• To test the hypothesis that specific dietary components in the LD diet inhibit ferroptosis and limit ALD progression.
• To develop a modified diet that promotes ferroptosis and induces advanced ALD features in mice.
• To establish a novel mouse model for studying advanced ALD.

Main Methods:

• Modified the LD diet to create a pro-ferroptotic LD (PFLD) diet by reducing vitamin E, increasing iron, and replacing monounsaturated fatty acids (MUFAs) with polyunsaturated fatty acids (PUFAs).
• Administered alcohol to mice via the PFLD diet.
• Assessed liver pathology, including fibrosis and macrosteatosis, and ferroptosis markers.

Main Results:

• Approximately 30% of mice fed alcohol via the PFLD diet developed liver fibrosis and macrosteatosis, characteristic of advanced ALD.
• These pathological changes were linked to heightened ferroptosis, potentially due to the accumulation of PUFA-containing triglycerides.
• Dietary lipid composition critically influences ALD severity.

Conclusions:

• The PFLD diet effectively models advanced alcoholic liver disease in mice.
• Dietary factors, particularly lipid composition and iron, play a crucial role in ALD progression by modulating ferroptosis.
• This new model provides a valuable tool for investigating advanced ALD pathogenesis and potential therapies.